Literature DB >> 21382510

Balancing multiple baseline characteristics in randomized clinical trials.

Zheng Su1.   

Abstract

It is of vital importance to the success of a randomized clinical trial to maintain the balance of baseline characteristics (covariates) that could potentially confound the outcomes of the trial. Various randomization methods have been proposed to increase the likelihood of having balanced covariates at the end of a trial, most of which only apply to categorical covariates. An optimization approach to maintaining the balance of multiple covariates in randomized clinical trials is proposed, which is applicable to both continuous and categorical covariates and allows the covariates to be ranked according to their clinical importance as perceived by the clinical trial practitioners. Simulation results show that the proposed algorithm significantly outperforms the standard randomization approach via flipping an unbiased coin. The proposed randomization method can be easily implemented and generalized for cases where there are multiple treatment arms with equal or unequal randomization probabilities.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21382510     DOI: 10.1016/j.cct.2011.03.004

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  3 in total

1.  Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies.

Authors:  Wenle Zhao; Yunming Mu; Darren Tayama; Sharon D Yeatts
Journal:  Contemp Clin Trials       Date:  2015-01-29       Impact factor: 2.226

2.  Dynamic randomization and a randomization model for clinical trials data.

Authors:  Lee D Kaiser
Journal:  Stat Med       Date:  2012-07-05       Impact factor: 2.373

3.  The Shiny Balancer - software and imbalance criteria for optimally balanced treatment allocation in small RCTs and cRCTs.

Authors:  Thomas Grischott
Journal:  BMC Med Res Methodol       Date:  2018-10-16       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.